Trial Profile
NZ PrEP: A demonstration project assessing the feasibility,acceptability,risks and benefits of prescribing tenofovir/emtricitabine (Truvada) in a sample of gay and bisexual men attending a sexual health clinic in Aotearoa, New Zealand
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Jul 2019
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms NZ PrEP
- Sponsors Gilead Sciences
- 08 Mar 2017 Status changed from not yet recruiting to recruiting.
- 07 Oct 2016 New trial record